Why hasn't MDCO stock price gone up? Its trading at the same level it was 14 years ago? What happens when Angiomax goes away (2015?). How do you plan to survive with all those cat 7 dog products. Nothing that can generate meaningful revenue. Regarding Oritivanvancin? Does it stay in the body for weeks or months? What are the implications for adverse reactions and resistsnce? Isn't it a 3 hour infusion? Doesnt Durata have a 1/2 hour infusion drug? Why use any of these products as they reduce clincal flexibility?
the culture Yes, the salaries here are high but understand that with that comes equally high expectations. We are on the device board because we are run like one. Perform and you will do well, if you don't perform you will be asked to leave quickly, there won't be any honeymoon period either. We are aggressive when it come to recruiting and equally aggressive when it comes to managing underperformers. Be prepared to work if you are coming, yes you will have a lot of freedom here. Do what you want to drive sales... but it better work so only self starters need apply. If you are looking for a cushy pharmacy job then stay away.
you must have a lot of turnover given recent sales performance. And prepare for backfills if Orita is approved.
I see that you are hiring a bunch if folks for a marginal drug. How patient will leadership be until layoffs come like before?
Then why hasn't your company valuation grown in over 14 years? You are also good at laying off the best in the world.
Question everyone should ask at interview is what percentage of company revenue is based on angiomax and what percentage will come from antibiotic?......tic-toc-tic-toc.....Bivalirudin patent is nearing....look at the history of the cleviprex expansion---nuff said
There is absolutely no way angiomax revenues are repaced anythme in the next 5-7 years with current pipeline. MDCO is overvalued and stock will head lowere after the PR machine settles down.
Has anyone heard that the generic company who bought Forrest (actavis?) is interested in us? In wonder what it would be like working for a generic company if they keep us? I guess I could ask the Forrest folks, at least the ones they haven't layed off.
Overbuilt for Angiomax - didnt grow - many had to go Overbuilding for Orbativ - nich product at best - keep your resume handy Look to the stock price to know objectively the poor performance of this company.
The Medicines Company did a number on CUBIST but we even robbed Durata of course. One Durata man apparently came over to MedCo as a new VP. He was a former Cubist RBD, Shannon M. Really on the move there! substantiated Rumor has it that a New VP who was hired by MedCo, was asked by MedCo about whether to hire certain people from Cubist. A lot of class demonstrated here if this is all true! It is all Bull Shit about the company and hiring the best people....at least with Integrity!
